Cornex

Manufacturer
Pella Pharmaceuticals Co. Ltd
Effective date
2025-01-22
Label type
HUMAN OTC DRUG LABEL
Version
242
Source
full-release
Hydrated at
2026-06-01 00:53:25

Label at a glance#

ProductCornex
Active ingredientLACTIC ACID, SALICYLIC ACID
Label structure14 sections

Dosage and administration

Remove any plaster and soak the wart in hot water for five minutes. Dry with your own towel. Rub the surface of the warts carefully with a pumice stone or emery board. Apply Cornex daily to the warts. Use only enough Cornex to cover the warts and avoid applying to the surrounding normal skin. Allow Cornex to dry and cover with plaster if the wart is large or on foot. Continue using Cemex daily until the wart is co...

Storage and handling

Store below 30 " C.

Label contents#

Full prescribing information#

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Each one gram contains: Lactic acid 167mg and salicylic acid 167mg.

Composition

INACTIVE INGREDIENT SECTION

Excipients: Alcohol, Hydroxypropyl Cellulose.

Properties

OTC - PURPOSE SECTION

Cornex is a topical gel for the removal of warts and corns.

Indications

INDICATIONS & USAGE SECTION

Cornex is used to remove Warts and Corns. A wart is a viral infection of the skin surface layer. The incubation period varies from a few weeks to several months. Warts can be spread by contact of the virus with damaged skin, particularly if warm and moist. This is why one of the most common sources of infection is swimming pools. Corns are hard, thick pads of skin caused by pressure and friction. They usually occur on the feet due to poorly fitting shoes. They can also occur on hands. Cornex Gel is suitable for use by adults, children and the elderly.

Contraindications

CONTRAINDICATIONS SECTION

Cornex is contraindicated in patients with known hypersensitivity to lactic acid and / or salicylic acid or to any other components of this product.
Do not use Cornex if you are diabetic or suffer from poor blood circulation to your hands or feet.

Precautions

PRECAUTIONS SECTION

Cornex is formulated for the controlled corrosion of keratin and thus care should be taken to apply the product to the wart only. Avoid applying it to normal surrounding skin. Do not use Cornex on the face, mucous membranes or anogenital reagions. Cornex is not recommended for use in infants under 2 years of age. Children under 12 years should only use the product under supervision.

Precaution

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

As well all the medicines you should keep Cornex out of reach of children.

Drug Interactions

DRUG INTERACTIONS SECTION

No interaction betyween Lactic acid and Salicylic acid and other drugs or substances are known or suspected.

Warnings

WARNINGS SECTION

Remember that warts are infectious. To prevent the infection spreading to others always keep to your own towel. Do not walk about barefoot if warts are on the soles of your feet. Be patient, it can take 6 to 12 weeks to completely remove the wart. Do not use Cornex on moles, brithmarks or unusual skin growths or near eyes or on mucous membranes.

Avoid use on broken or inflamed skin.

Dosage and Administration

DOSAGE & ADMINISTRATION SECTION

Remove any plaster and soak the wart in hot water for five minutes. Dry with your own towel. Rub the surface of the warts carefully with a pumice stone or emery board. Apply Cornex daily to the warts. Use only enough Cornex to cover the warts and avoid applying to the surrounding normal skin.

Allow Cornex to dry and cover with plaster if the wart is large or on foot. Continue using Cemex daily until the wart is completely cleared and the ridge lines of the skin have been restored.

Side Effects

ADVERSE REACTIONS SECTION

Avoid use on large areas of skin; as this may result in absorption of sufficient quantities to cause adverse effects.

Storage

STORAGE AND HANDLING SECTION

Store below 30 " C.

How supplied

HOW SUPPLIED SECTION

15 g packs.

Secondary Package

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Secondary PackageSecondary Package

Primary Package

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Primary PackagePrimary Package

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
244534lactic acid 16.7 % / salicylic acid 16.7 % Topical GelPSN242
244534lactic acid 0.167 MG/MG / salicylic acid 0.167 MG/MG Topical GelSCD242
244534lactic acid 16.7 % / salicylic acid 16.7 % Topical GelSY242
244534lactic acid 167 MG / salicylic acid 167 MG per 1 GM Topical GelSY242

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
LACTIC ACID, UNSPECIFIED FORM Pharmacologic Class Indexing1Indexing - Pharmacologic Class20220121

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
f52be47f-7aa7-46c0-b1fa-50c18dd50206Product name120201029
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
597b1cfd-7b31-5048-62be-ca5cd740da2fProduct name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
82160-238-01Cornex15 g in 1 TUBEGEL15242
82160-238-01Cornex1 in 1 CARTONGEL1242

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
82160-238CORNEX (LACTIC ACID, SALICYLIC ACID) GEL [PELLA PHARMACEUTICALS CO. LTD]242Legacy NDC, 2 package rows20250123_d0d10aa0-063e-0160-e053-2995a90a3b88.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
82160-23882160-238-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
2c493a3f-fb3a-99fc-e063-6394a90a76a8d0d10aa0-063e-0160-e053-2995a90a3b882025-01-22Warnings, Adverse reactionsExact identifier
spl id: 2c493a3f-fb3a-99fc-e063-6394a90a76a8
spl set id: d0d10aa0-063e-0160-e053-2995a90a3b88

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.